Noncellular and cellular in vitro models for predicting intestinal absorption were used to investigate the transport and metabolism of parabens. The biomimetic artificial membrane permeability assay (BAMPA) membrane was constructed by impregnating a lipid solution on a hydrophobic filter. Caco-2 cells at passage numbers 65 to 80 were cultured in either the accelerated 3-day Biocoat™ system or the standard 21-day Transwell™ cell culture system. Paraben transport across the BAMPA system showed a parabolic relationship. The lowest log P (p-hydroxybenzoic acid) and highest log P compounds (heptyl and octyl parabens) had apparent permeabilities (Papp) less than 1.0 × 10-6 cm/s and Papp was maximal at approximately 8.5 × 10-6cm/s for the intermediate log P (ethylparaben) compound. With the Biocoat™, a similar parabolic relationship was found. In the 21-day Caco-2 cells, the parabens were metabolized by esterases at to p-hydroxybenzoic acid. In conclusion, the in vitro models added complementary insight into the absorption process, such as the transport route, intrinsic permeability, and extent of metabolism of the parabens. This study indicated that presystemic metabolism of orally ingested parabens to the p-hydroxybenzoic acid in the intestine may limit systemic exposure to alkyl-paraben esters in vivo.
Soni MG, Taylor SL, Greenberg NA, Burdock GA: Evaluation of the health aspects of methyl paraben: a review of the published literature. Food Chem Toxicol2002;40:1335-1373.
2.
Jones BE: Gelatin alternatives and additives. In Podczeck P, Jones BE (eds): Pharmaceutical Capsules. 2nd ed.London: Pharmaceutical Press, 2004:70-71.
3.
Golden R, Gandy J, Vollmer G: A review of the endocrine activity of parabens and implications for potential risks to human health. Crit Rev Toxicol2005;35:435-458.
4.
Soni MG, Carabin IG, Burdock GA: Safety assessment of esters of p-hydroxybenzoic acid (parabens). Food Chem Toxicol2005;43:985-1015.
5.
Tsukatmoto H, Teranda S: Metabolism of drugs: XXVI. Metabolic fate of p-hydroxybenzoic acid and its derivatives in rabbits. Chem Pharm Bull1962;10:86-90.
6.
Tsukatmoto H, Teranda S: Metabolism of drugs: XLVII. Metabolic fate of p-hydroxybenzoic acid and its derivatives in rabbits. Chem Pharm Bull1964;12:765-769.
7.
Artursson P, Palm K, Luthman K: Caco-2 monolayers in experimental and theoretical predictions of drug transport. Adv Drug Deliv Rev2001;46:27-43.
8.
Gan LS, Thakker DR: Applications of the Caco-2 model in the design and development of orally active drugs: elucidation of biochemical and physical barriers posed by the intestinal epithelium. Adv Drug Deliv Rev1997;23:77-98.
9.
Elder RL: Final report on the safety assessment of methylparaben, ethylparaben, propylparaben and butylparaben. J Am Coll Toxicol1984;3:147-209.
10.
Nakagawa Y, Moldeus P: Mechanism of p-hydroxybenzoate ester-induced mitochondrial dysfunction and cytotoxicity in isolated rat hepatocytes. Biochem Pharmacol1998;55:1907-1914.
11.
Sugano K, Hamada H, Machida M, Ushio H: High throughput prediction of oral absorption: improvement of the composition of the lipid solution used in parallel artificial membrane permeation assay. J Biomol Screen2001;6:189-196.
12.
Kansy M, Avdeef A, Fischer H: Advances in screening for membrane permeability: high-resolution PAMPA for medicinal chemists. Drug Discov Today2004;1:346-355.
13.
Delie F, Rubas W: A human colonic cell line sharing similarities with enterocytes as a model to examine oral absorption: advantages and limitations of the Caco-2 model. Crit Rev Ther Drug Carrier Syst1997;14:221-286.
14.
Annaert P, Kinget R, Naesens L, de Clercq E, Augustijns P: Transport, uptake and metabolism of the bis (pivaloyloxymethyl)-ester prodrug of 9-(2-phosphonylmethoxyethyl) adenine in an in vitro cell culture system of the intestinal mucosa (Caco-2). Pharm Res1997;14:492-496.
15.
Augustijns P, Annaert P, Hevlen P, Van der Mooter G, Kinget R: Drug absorption studies of prodrug esters using the Caco-2 model: evaluation of ester hydrolysis and transepithelial transport. Int J Pharm1998;166:45-53.
16.
Chong S, Dando SA, Morrison RA: Evaluation of Biocoat® intestinal epithelium differentiation environment (3 day cultured Caco-2 cells) as an absorption screening model with improved productivity. Pharm Res1997;14:1835-1837.
17.
Pease CK, Kino-Thompson J, Sanders D, Pendlington RU, York M, McEwan A, et al: Biokinetic equivalence of propylparaben and octylparaben: in vitro metabolism data and single dose oral administration study in man. Drug Metab Dispos; in press.
18.
Sugano K, Takata N, Machida M, Saitoh K, Terada K: Prediction of passive intestinal absorption using bio-mimetic artificial membrane permeation assay and the paracellular pathway model. Int J Pharm2002;241:241-251.
19.
Schmitz J, Preiser H, Maestracci D, Ghosh BK, Cerda JJ, Crane RK: Purification of the human intestinal brush border membrane. Biochim Biophys Acta1973;323:98-112.
20.
Wils P, Warnery A, Phung-Ba V, Legrain S, Scherman D: High lipophilicity decreases drug transport across intestinal epithelial cells. J Pharmacol Exp Ther1994;269:654-658.
21.
Malkia A, Murtomaki L, Urtti A, Kontturi K: Drug permeation in biomembranes: in vitro and in silico prediction and influence of physicochemical properties. Eur J Pharm Sci2004;23:13-47.
22.
Gutknecht J, Tosteson DC: Diffusion of weak acids across lipid membranes: effects of chemical reactions in the unstirred layers. Science1973;182:1258-1261.
23.
Neuhoff S, Ungell A-L, Zamora I, Artursson P: pH-Dependent passive and active transport of acidic drugs across Caco-2 cell monolayers. Eur J Pharm Sci2005;25:211–220.
24.
Lobemeier C, Tschoetschel C, Westie S, Heymann E: Hydrolysis of parabenes by extracts from differing layers of human skin. Biol Chem1996;377:647–651.
25.
Rothen-Rutishauser B, Braun A, Gunthert M, Wunderli-Allenspach H: Formation of multilayers in the Caco-2 cell culture model: a confocal laser scanning microscopy study. Pharm Res2000;17:460-465.
26.
Yamashita S, Konishi K, Yamazaki Y, Taki Y, Sakane T, Sezaki H, et al: New and better protocols for a short term Caco-2 cell culture system. J Pharm Sci2002;91:669-679.
27.
Bravo SA, Nielsen CU, Amstrup J, Frokjaer S, Brodin B: In-depth evaluation of Gly-Sar transport parameters as a function of culture time in the Caco-2 cell model. Eur J Pharm Sci2004;21:77–86.
28.
Hovgaard L, Brondsted H, Buur A, Bundgaard H: Drug delivery studies in Caco-2 monolayers: synthesis, hydrolysis and transport of O-cyclopropane carboxylic acid ester prodrugs of various [.mu]-blocking agents. Pharm Res1995;12:387-392.
29.
Konishi Y, Kobayashi S, Shimizu M: Transepithelial transport of p-coumaric acid and gallic acid by monocarboxylic acid transporter in Caco-2 cell monolayers. Biosci Biotechnol Biochem2003;67:2317-2324.
30.
Miret S, Abrahamse L, de Groene EM: Comparison of in vitro models for the prediction of compound absorption across the human intestinal mucosa. J Biomol Screen2004;9:598-606.
